Cargando…

CD133+ liver cancer stem cells resist interferon-gamma-induced autophagy

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most fatal malignancies worldwide, and CD133 is a popular cancer stem cell (CSC) marker for HCC. CD133(+) CSCs have been reported to resist conventional chemo- and radiotherapy, but little is known about their response to immune surveillance....

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jian, Chen, Jin-Na, Zeng, Ting-Ting, He, Fan, Chen, Shu-Peng, Ma, Stephanie, Bi, Jiong, Zhu, Xiao-Feng, Guan, Xin-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711109/ https://www.ncbi.nlm.nih.gov/pubmed/26758620 http://dx.doi.org/10.1186/s12885-016-2050-6

Ejemplares similares

Inhibition of Autophagy Promotes the Elimination of Liver Cancer Stem Cells by CD133 Aptamer-Targeted Delivery of Doxorubicin
por: Yin, Wang, et al.
Publicado: (2022)

Biological characteristics of CD133(+) cells in nasopharyngeal carcinoma
por: ZHUANG, HUI-WEN, et al.
Publicado: (2013)

Isolation of CD133+ Liver Stem Cells for Clonal Expansion
por: Rountree, C. Bart, et al.
Publicado: (2011)

Molecular Regulation of Autophagy and Asymmetric Cell Division by Cancer Stem Cell Marker CD133
por: Izumi, Hideki, et al.
Publicado: (2023)

Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer
por: Chen, Wei-Ching, et al.
Publicado: (2015)

Label-free quantitative proteomics of CD133-positive liver cancer stem cells
por: Tsai, Sheng-Ta, et al.
Publicado: (2012)

Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133(+) osteosarcoma cancer stem cells
por: Ni, Miaozhong, et al.
Publicado: (2015)

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)

Regulation of CD47 expression by interferon-gamma in cancer cells
por: Ye, Zi-Han, et al.
Publicado: (2021)

Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma
por: Wang, Jian‐Hua, et al.
Publicado: (2019)

Recycling endosomal CD133 functions as an inhibitor of autophagy at the pericentrosomal region
por: Izumi, Hideki, et al.
Publicado: (2019)

Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133
por: Hur, Wonhee, et al.
Publicado: (2017)

CD133: a stem cell biomarker and beyond
por: Li, Zhong
Publicado: (2013)

Prostate Cancer Stem Cells: The Role of CD133
por: Yang, Jianhui, et al.
Publicado: (2022)

Bone Marrow CD133(+) Stem Cells Ameliorate Visual Dysfunction in Streptozotocin-induced Diabetic Mice with Early Diabetic Retinopathy
por: Rong, Liyuan, et al.
Publicado: (2018)

Resistance of glioma cells to nutrient-deprived microenvironment can be enhanced by CD133-mediated autophagy
por: Sun, Haojie, et al.
Publicado: (2016)

CD133, Stem Cells, and Cancer Stem Cells: Myth or Reality?
por: Yu, Xiazhen, et al.
Publicado: (2011)

Isolation and characteristics of CD133(−)/A2B5(+) and CD133(−)/A2B5(−) cells from the SHG139s cell line
por: HAN, YONG, et al.
Publicado: (2015)

CD133/Prominin-1-Mediated Autophagy and Glucose Uptake Beneficial for Hepatoma Cell Survival
por: Chen, Haiyang, et al.
Publicado: (2013)

The Potential Role of CD44 and CD133 in Colorectal Stem Cell Cancer
por: Abdou Hassan, Wael, et al.
Publicado: (2022)

Analysis of gene expression and chemoresistance of CD133(+ )cancer stem cells in glioblastoma
por: Liu, Gentao, et al.
Publicado: (2006)

$\beta$ decay of $^{133}$In : $\gamma$ emission from neutron-unbound states in $^{133}$Sn
por: Piersa, M., et al.
Publicado: (2019)

Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma
por: Liu, Chao Lien, et al.
Publicado: (2020)

Potential Role of CD133 Expression in the Susceptibility of Human Liver Cancer Stem-Like Cells to TRAIL
por: Lee, Su-Hoon, et al.
Publicado: (2016)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells
Publicado: (1993)

Inhibitory effects of transcription factor Ikaros on the expression of liver cancer stem cell marker CD133 in hepatocellular carcinoma
por: Zhang, Lin, et al.
Publicado: (2014)

Role of the Hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133(+) pancreatic cancer stem-like cells
por: Zhu, Haitao, et al.
Publicado: (2013)

Cancer stem cells CD133 and CD24 in colorectal cancers in Northern Iran
por: Nosrati, Anahita, et al.
Publicado: (2016)

Cancer Stem Cell Markers CD44, CD133 in Primary Gastric Adenocarcinoma
por: Nosrati, Anahita, et al.
Publicado: (2014)

Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer
por: WANG, CHUNXIA, et al.
Publicado: (2012)

Prognostic value of CD133(+) CD54(+) CD44(+) circulating tumor cells in colorectal cancer with liver metastasis
por: Fang, Chao, et al.
Publicado: (2017)

CD133(+) cancer stem cells promoted by VEGF accelerate the recurrence of hepatocellular carcinoma
por: Liu, Kai, et al.
Publicado: (2017)

CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells
por: Barrantes-Freer, Alonso, et al.
Publicado: (2015)

Interferon gamma in cancer immunotherapy
por: Ni, Ling, et al.
Publicado: (2018)

Spred2 controls the severity of Concanavalin A-induced liver damage by limiting interferon-gamma production by CD4(+) and CD8(+) T cells
por: Sun, Cuiming, et al.
Publicado: (2021)

Epigenetic Control of Interferon-Gamma Expression in CD8 T Cells
por: de Araújo-Souza, Patrícia S., et al.
Publicado: (2015)

Role of ADAM17 in invasion and migration of CD133-expressing liver cancer stem cells after irradiation
por: Hong, Sung Woo, et al.
Publicado: (2016)

Suitability of CD133 as a Marker for Cancer Stem Cells in Melanoma
por: Korn, Philippe, et al.
Publicado: (2021)

Immunohistochemical Expression of the Stem Cell Marker CD133 in Colorectal Carcinoma
por: Suman, Sweta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_knpqcsu630aji4jhei1kcgcna2